Management of Prosthetic Aortic Valve Endocarditis with Root Abscess After Surgical Intervention

Duration of Antimicrobial Therapy

The American Heart Association recommends at least 6 weeks of IV antimicrobial therapy for prosthetic valve endocarditis, which serves as the initial treatment phase 2
Following completion of the initial 6 weeks of IV therapy, an additional 3-6 months of oral antimicrobial therapy is recommended for patients with prosthetic valve infections, especially those with extensive perigraft infection 1
The decision to extend treatment with oral antibiotics should be individualized based on the specific microorganism (Streptococcus mitis/oralis) and the presence of persistently elevated inflammatory markers such as erythrocyte sedimentation rate and C-reactive protein 3, 1

The presence of an aortic root abscess represents a complex infection with higher risk of treatment failure and relapse, warranting extended antimicrobial coverage 1, 5
Streptococcus mitis/oralis, while generally susceptible to penicillins, has shown increasing rates of resistance (>30% of strains show intermediate or full resistance), potentially requiring more aggressive treatment approaches 4

The choice of oral antibiotics should be based on susceptibility testing of the Streptococcus mitis/oralis isolate 4
For penicillin-susceptible strains, amoxicillin would be the preferred oral option 6, 4
For patients with penicillin allergies or resistant strains, consultation with infectious disease specialists is essential to select appropriate alternatives 7, 4

Periodic monitoring of inflammatory markers (ESR, CRP) should be performed to assess treatment response 1
Follow-up echocardiography is recommended to evaluate for vegetation resolution and to detect any early signs of recurrence 7

The decision for lifelong suppressive therapy may be considered in select high-risk patients, particularly those with extensive perigraft infection 1, 5
Consultation with infectious disease specialists is strongly recommended for determining the optimal duration and selection of antimicrobial agents 4
If oral therapy is not feasible or ineffective, consideration of chronic intermittent IV antimicrobial suppressive therapy (2-3 times weekly) may be necessary 1

Premature discontinuation of antibiotics before completing the recommended extended course increases the risk of relapse 2
Failure to monitor inflammatory markers during extended therapy may miss early signs of recurrent infection 1
Inadequate follow-up imaging to assess for resolution of infection or development of complications 7